CORE releases statement on mifepristone ruling

While legal challenges to the United States Food and Drug Administration’s approval of the medication mifepristone work their way through the courts, the UW Collaborative for Reproductive Equity is tracking the decisions and their potential impact on health care in Wisconsin.

CORE published an update in late April after the U.S. Supreme Court’s ruling that temporarily protected access to mifepristone while cases continue through lower courts: 

“While mifepristone’s use will remain intact elsewhere where legal, it still cannot be used for abortion care in Wisconsin. Due to the overturning of Roe v. Wade and an 1849 abortion ban, medication abortion is not currently available through the formal healthcare system in Wisconsin unless to save the life of the pregnant person.”

You can read the whole mifepristone update here. CORE has compiled a variety of resources about abortion access and restrictions following the Dobbs decision in June 2022. Keep up with the latest information on the CORE After Roe page.